Tirzepatide with Ixekizumab enhances psoriatic arthritis control in obese patients.
Combination of Biologic and Anti-obesity Therapies in Psoriatic Arthritis
Abstract
Combining Tirzepatide with Ixekizumab significantly improved disease control in adults with psoriatic arthritis and obesity compared to Ixekizumab alone.
TitrateLab articles covering Tirzepatide
Written by TitrateLab, separately from the study summarized above.
